<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02841488</url>
  </required_header>
  <id_info>
    <org_study_id>CAAE: 55187516.4.0000.0068</org_study_id>
    <nct_id>NCT02841488</nct_id>
  </id_info>
  <brief_title>Ischemic Pain Control With Analgesic Methods Clinical Trial</brief_title>
  <acronym>ISCHAEMIC</acronym>
  <official_title>Comparative Study Between Systemic Analgesia and Continuous Sciatic Nerve Block in Patients With Chronic Obstructive Arterial Disease and Ischemic Pain in Lower Limbs</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sao Paulo General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project is one of four components of a thematic project that aims to evaluate the use of
      ultrasound in regional blocks, called &quot;Use of ultrasound in regional blocks and injections
      for the treatment of acute and chronic pain.&quot;

      It will evaluate quantitative and qualitative control of ischemic pain in the lower limbs in
      patients with peripheral arterial occlusive disease through continuous sciatic nerve block by
      perineural catheter, popliteal approach, compared to systemic analgesia based on opioids.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      BACKGROUND: Peripheral arterial occlusive disease (PAOD) commonly evolves with intense
      ischemic pain in the lower limbs, which is hard to control with systemic analgesics, and
      continuous regional anesthesia may be an alternative, with adequate analgesia and lower
      incidence of side effects.

      OBJECTIVES: evaluate qualitative and quantitative pain control, incidence of adverse effects
      and operative results in patients with PAOD undergoing continuous anesthetic blockade of the
      sciatic nerve by perineural catheter compared to systemic analgesia based on opioids and
      adjuvant medications.

      METHODS: It is a randomized clinical trial, covered for evaluators. It will include 56
      patients with PAOD Fontaine IV, with pain by the presence of ulcerations located on foot. A
      group will be submitted to continuous regional anesthesia of sciatic nerve through perineural
      catheter and another group will have its pain control through patient controlled analgesia
      device with intravenous fentanyl. The primary dependent variable will be pain, through the
      numerical pain scale.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">October 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain intensity</measure>
    <time_frame>up to 28th day</time_frame>
    <description>Verbal numerical scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Opioids Adverse effects</measure>
    <time_frame>up to 28th day</time_frame>
    <description>Nausea, vomiting, constipation, sedation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">56</enrollment>
  <condition>Arterial Occlusive Diseases</condition>
  <arm_group>
    <arm_group_label>Continuous nerve block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Continuous peripheral sciatic nerve block through popliteal perineural catheter with ropivacaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Systemic analgesia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intravenous fentanyl patient controlled analgesia device</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Continuous peripheral sciatic nerve block</intervention_name>
    <description>Continuous infusion of local anesthetics through perineural sciatic nerve catheter</description>
    <arm_group_label>Continuous nerve block</arm_group_label>
    <other_name>Perineural sciatic catheter</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl</intervention_name>
    <description>Use of patient controlled analgesia device with intravenous fentanyl</description>
    <arm_group_label>Systemic analgesia</arm_group_label>
    <other_name>Intravenous fentanyl</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine</intervention_name>
    <arm_group_label>Continuous nerve block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Perineural catheter</intervention_name>
    <arm_group_label>Continuous nerve block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients older than 18 years old who have strong or moderate persistent ischemic pain
             in the lower limbs, due to peripheral artery occlusive disease, classified as Fontaine
             IV (pain at rest and presence of ulcer or gangrene).

        Exclusion Criteria:

          -  Uncooperative patients, coagulation disorders, patients with liver failure, who have
             atrioventricular block second or third degree, who refuse to be submitted to
             peripheral nerve block, with systemic or procedure site local infection infection,
             peripheral or central neuropathy history, allergies to local anesthetics or to any of
             the drugs to be used in the study and difficulty in understanding the use of the PCA
             (patient-controlled analgesia) device and evaluation methods used in the study .
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joaquim E Vieira, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Professor</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hermann S Fernandes, MD</last_name>
    <phone>+55 84 988966348</phone>
    <email>hermann.fernandes@hc.fm.usp.br</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hazem A Ashmawi, PhD</last_name>
    <phone>+55 11 985733798</phone>
    <email>hazem.ashmawi@hc.fm.usp.br</email>
  </overall_contact_backup>
  <reference>
    <citation>Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation. 2004 Aug 10;110(6):738-43. Epub 2004 Jul 19.</citation>
    <PMID>15262830</PMID>
  </reference>
  <reference>
    <citation>Navas-Acien A, Selvin E, Sharrett AR, Calderon-Aranda E, Silbergeld E, Guallar E. Lead, cadmium, smoking, and increased risk of peripheral arterial disease. Circulation. 2004 Jun 29;109(25):3196-201. Epub 2004 Jun 7.</citation>
    <PMID>15184277</PMID>
  </reference>
  <reference>
    <citation>Belch JJ, Topol EJ, Agnelli G, Bertrand M, Califf RM, Clement DL, Creager MA, Easton JD, Gavin JR 3rd, Greenland P, Hankey G, Hanrath P, Hirsch AT, Meyer J, Smith SC, Sullivan F, Weber MA; Prevention of Atherothrombotic Disease Network. Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med. 2003 Apr 28;163(8):884-92. Review.</citation>
    <PMID>12719196</PMID>
  </reference>
  <reference>
    <citation>McDaniel MD, Cronenwett JL. Basic data related to the natural history of intermittent claudication. Ann Vasc Surg. 1989 Jul;3(3):273-7. Review.</citation>
    <PMID>2673321</PMID>
  </reference>
  <reference>
    <citation>Marquis P, Lecasble M, Passa P. [Quality of life of patient with peripheral arterial obliterative disease treated with ifenprodil tartrate. Results of an ARTEMIS study]. Drugs. 1998;56 Suppl 3:37-48. French.</citation>
    <PMID>9844701</PMID>
  </reference>
  <reference>
    <citation>Campbell WB, Marriott S, Eve R, Mapson E, Sexton S, Thompson JF. Anaesthesia and analgesia for major lower limb amputation. Cardiovasc Surg. 2000 Dec;8(7):572-5.</citation>
    <PMID>11068220</PMID>
  </reference>
  <reference>
    <citation>Ilfeld BM. Continuous peripheral nerve blocks: a review of the published evidence. Anesth Analg. 2011 Oct;113(4):904-25. doi: 10.1213/ANE.0b013e3182285e01. Epub 2011 Aug 4. Review.</citation>
    <PMID>21821511</PMID>
  </reference>
  <reference>
    <citation>Capdevila X, Ponrouch M, Choquet O. Continuous peripheral nerve blocks in clinical practice. Curr Opin Anaesthesiol. 2008 Oct;21(5):619-23. doi: 10.1097/ACO.0b013e32830c66c2. Review.</citation>
    <PMID>18784489</PMID>
  </reference>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 17, 2016</study_first_submitted>
  <study_first_submitted_qc>July 21, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 22, 2016</study_first_posted>
  <last_update_submitted>July 21, 2016</last_update_submitted>
  <last_update_submitted_qc>July 21, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sao Paulo General Hospital</investigator_affiliation>
    <investigator_full_name>Hermann dos Santos Fernandes</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arterial Occlusive Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <study_docs>
    <study_doc>
      <doc_type>Informed Consent Form</doc_type>
      <doc_url>http://aplicacao.saude.gov.br/plataformabrasil/visao/pesquisador/gerirPesquisa/gerirPesquisaAgrupador.jsf</doc_url>
    </study_doc>
  </study_docs>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

